drugset / Trial / NCT03151148
Targeted Microbiome Transplant in Atopic Dermatitis
Phase 1/2
Completed
54 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis Research Network · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to examine the safety and effectiveness of a new therapy, commensal lotion containing infection fighting bacteria, on decreasing or eliminating the infection causing bacteria found on the skin of Atopic Dermatitis (AD) patients.
Timeline
- Start
- 2017-09-28
- Primary completion
- 2019-05-14
- Completion
- 2019-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ShA9 | Other / unclassified | 2 g | Topical |